From November 20, 2023 to December 31, 2023, the company has repurchased 7,201,500 shares, representing 1.35% for CNY 95.84 million. With this, the company has completed the repurchase of 7,201,500 shares, representing 1.35% for CNY 95.84 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 CNY | +1.79% | -4.91% | -36.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.56% | 603M | |
-1.96% | 287B | |
-7.08% | 90.96B | |
-9.28% | 41.76B | |
+1.12% | 41.74B | |
+2.51% | 39.65B | |
+2.70% | 38.08B | |
-14.22% | 30.29B | |
-4.23% | 28.91B | |
+7.56% | 24.27B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.